-
Chugai obtains approval for FoundationOne CDx Cancer Genomic Profile to be used as a companion diagnostic for repotrectinib with NTRK fusion─positive solid─tumours
21 Nov 2025 05:02 GMT
… NTRK fusion-positive solid-tumours. Bristol-Myers Squibb K.K. obtained a partial … Japan.
“We are pleased that FoundationOne CDx Cancer Genomic Profile was … Genomic Profiling.
Developed by Foundation Medicine Inc., FoundationOne CDx Cancer Genomic Profile …
-
Bristol-Myers Squibb Company (NYSE:BMY) Q2 2025 Earnings Call Transcript
01 Aug 2025 14:05 GMT
… Call Transcript July 31, 2025
Bristol-Myers Squibb Company beats earnings expectations. Reported … threshold within the context of Bristol-Myers Squibb.
Christopher S. Boerner: Thanks for … put together a very nice foundation that Cristian will benefit from …
-
Bristol-Myers Squibb Company Names Wendy Short Bartie Executive Vice President, Corporate Affairs
07 Jun 2025 05:51 GMT
Bristol-Myers Squibb Company names Wendy Short Bartie, … oversee the Bristol Myers Squibb Foundation, an independent organization that works …
-
Global Research Trends in Apremilast for Psoriasis: A Bibliometric Analysis (2008–2024)
09 Dec 2025 16:28 GMT
… with 96 publications, followed by Bristol-Myers Squibb (61) and Icahn School of … articles, indicating a shared intellectual foundation or research focus.
Analysis … Board of the National Psoriasis Foundation: perioperative management of systemic …
-
Bristol-Myers Squibb Children’s Hospital opens same-day center (photos)
21 May 2025 21:06 GMT
The Bristol-Myers Squibb Children’s Hospital … Squibb Foundation helped fund the location. The Bristol-Myers Squibb center … to RWJBarnabas Health, the foundation’s gifts to BMSCH … administrative officer, called the foundation “an outstanding partner.” Chaknis …
-
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) stands out as a stock that provides good value for the fundamentals it showcases.
09 May 2025 14:54 GMT
… stock screening tool has pinpointed BRISTOL-MYERS SQUIBB CO (NYSE:BMY) as an … . BMY retains a strong financial foundation and an attractive price tag …
-
Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025
08 Dec 2025 22:49 GMT
… a secondary malignancy occurs, contact Bristol-Myers Squibb at 1-888-805-4555 … . We are building on this foundation with several investigational protein degraders …
-
Bristol-Myers Squibb Company (NYSE:BMY) Q1 2025 Earnings Call Transcript
25 Apr 2025 12:22 GMT
… Call Transcript April 24, 2025
Bristol-Myers Squibb Company beats earnings expectations. Reported … for Cobenfi to become the foundational treatment. As I mentioned earlier … on execution is strengthening our foundation and positioning the company to …
-
2025 New Jersey Businesses Power List: Q – S
08 Dec 2025 07:13 GMT
… donation to the Stockton University Foundation, bringing the total amount contributed … Newark Beth Israel Medical Center, Bristol-Myers Squibb Children’s Hospital, Virtua Voorhees …
-
K36 Therapeutics announces presentation of First-in-Human Clinical Data for Gintemetostat (KTX-1001) Demonstrating Target Engagement and Clinical Activity in Multiple Myeloma at ASH 2025 and the Appointment of Dr. Shinta Cheng, M.D., Ph.D., as Chief…
05 Dec 2025 13:55 GMT
… support its potential as a foundational therapy for patients with t … for nivolumab and ipilimumab at Bristol-Myers Squibb, where he advanced early clinical …
About
© 1995-2025